Buy Or Sell Opportunity • Jun 08
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 30% to CN¥27.90. The fair value is estimated to be CN¥35.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 20%. For the next 3 years, revenue is forecast to grow by 9.0% per annum. Earnings are also forecast to grow by 21% per annum over the same time period. Reported Earnings • Apr 23
First quarter 2026 earnings released: EPS: CN¥0.14 (vs CN¥0.14 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.14. Revenue: CN¥2.44b (up 14% from 1Q 2025). Net income: CN¥106.7m (up 1.5% from 1Q 2025). Profit margin: 4.4% (down from 4.9% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Annonce • Apr 23
SKSHU Paint Co.,Ltd., Annual General Meeting, May 13, 2026 SKSHU Paint Co.,Ltd., Annual General Meeting, May 13, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Putian, Fujian China Annonce • Mar 30
SKSHU Paint Co.,Ltd. to Report Q1, 2026 Results on Apr 23, 2026 SKSHU Paint Co.,Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026 Buy Or Sell Opportunity • Mar 23
Now 21% undervalued Over the last 90 days, the stock has risen 5.3% to CN¥46.76. The fair value is estimated to be CN¥59.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 21% in 2 years. Earnings are forecast to grow by 101% in the next 2 years. Annonce • Jan 26
3Trees Unveils Climate-Resilient Coating Solutions At Big 5 Construct Saudi, Enhancing Sustainable Building Standards in the Middle East SKSHU Paint Co. Ltd. showcased its latest range of high-performance, climate-adaptive products at Big 5 Construct Saudi, the Middle East's premier construction industry event. The display reflected a broader industry shift toward integrated, sustainable technologies that enhance durability, energy efficiency, and indoor environmental quality. As construction across the Gulf accelerates, developers face growing pressure to meet higher environmental and performance standards. In response, 3Trees's exhibition introduced three core solutions to address these challenges: weather-resistant stone-effect coatings, odorless interior wall paints, and radiative cooling coatings designed to reduce surface heat loads. The lineup was developed to support developers in achieving greater long-term building resilience and occupant well-being under high-heat, high-UV conditions. Visitors explored hands-on demo zones that turned technical features into real-world experiences. Thermal imaging demonstrated how radiative cooling coatings kept surfaces cooler than conventional options under the same lighting, pointing to their energy-saving potential and HVAC benefits. 3Trees also highlighted its local customization capabilities, showcasing stone-textured finishes and color treatments shaped by regional design trends. These lightweight materials suit large and high-rise projects, offering efficiency gains that matter for developers balancing performance and cost. As indoor air quality becomes a growing priority, 3Trees's odorless wall paint drew strong interest for its low-emission, low-odor formula. Designed for quick project turnaround and move-in readiness, it offers a cleaner, more comfortable option for high-end homes, hotels, and commercial spaces. Beyond individual products, the company focused on its full-system approach, providing support from product selection and color design to technical guidance and on-site application. Each display sample was tailored to local trends, reflecting 3Trees's attention to climate, aesthetics, and compliance in every detail. The Middle East construction sector is moving toward materials that blend design, strength, and sustainability. 3Trees's presence at Big 5 showcased solutions that support a more sustainable, efficient, and comfortable built environment through ongoing innovation and local collaboration. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥51.50, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 27x in the Chemicals industry in China. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥54.28 per share. Buy Or Sell Opportunity • Jan 15
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.8% to CN¥43.12. The fair value is estimated to be CN¥53.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 22% in 2 years. Earnings are forecast to grow by 94% in the next 2 years. Annonce • Dec 26
SKSHU Paint Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026 SKSHU Paint Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026 Buy Or Sell Opportunity • Nov 19
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 7.8% to CN¥42.67. The fair value is estimated to be CN¥54.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 22% in 2 years. Earnings are forecast to grow by 94% in the next 2 years. Buy Or Sell Opportunity • Nov 04
Now 21% undervalued Over the last 90 days, the stock has risen 8.7% to CN¥43.05. The fair value is estimated to be CN¥54.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 23% in 2 years. Earnings are forecast to grow by 90% in the next 2 years. Reported Earnings • Oct 19
Third quarter 2025 earnings: EPS exceeds analyst expectations Third quarter 2025 results: EPS: CN¥0.42 (up from CN¥0.27 in 3Q 2024). Revenue: CN¥3.58b (up 5.6% from 3Q 2024). Net income: CN¥307.8m (up 54% from 3Q 2024). Profit margin: 8.6% (up from 5.9% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Annonce • Sep 30
SKSHU Paint Co.,Ltd. to Report Q3, 2025 Results on Oct 18, 2025 SKSHU Paint Co.,Ltd. announced that they will report Q3, 2025 results on Oct 18, 2025 Major Estimate Revision • Aug 22
Consensus EPS estimates increase by 11%, revenue downgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from CN¥13.4b to CN¥13.1b. EPS estimate rose from CN¥1.06 to CN¥1.18. Net income forecast to grow 71% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥37.45 to CN¥42.08. Share price rose 5.2% to CN¥47.78 over the past week. Reported Earnings • Aug 19
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Second quarter 2025 results: EPS: CN¥0.45 (up from CN¥0.22 in 2Q 2024). Revenue: CN¥3.69b (flat on 2Q 2024). Net income: CN¥330.7m (up 103% from 2Q 2024). Profit margin: 9.0% (up from 4.4% in 2Q 2024). Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) also surpassed analyst estimates by 72%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Price Target Changed • Aug 18
Price target increased by 11% to CN¥41.61 Up from CN¥37.45, the current price target is an average from 8 analysts. New target price is 6.4% below last closing price of CN¥44.46. Stock is up 119% over the past year. The company is forecast to post earnings per share of CN¥1.09 for next year compared to CN¥0.45 last year. Price Target Changed • Aug 17
Price target increased by 8.4% to CN¥39.59 Up from CN¥36.51, the current price target is an average from 8 analysts. New target price is 13% below last closing price of CN¥45.42. Stock is up 120% over the past year. The company is forecast to post earnings per share of CN¥1.07 for next year compared to CN¥0.45 last year. Price Target Changed • Jul 18
Price target increased by 9.8% to CN¥37.48 Up from CN¥34.13, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CN¥37.80. Stock is up 46% over the past year. The company is forecast to post earnings per share of CN¥1.06 for next year compared to CN¥0.45 last year. Price Target Changed • Jul 14
Price target increased by 10% to CN¥36.51 Up from CN¥33.18, the current price target is an average from 8 analysts. New target price is 5.6% below last closing price of CN¥38.69. Stock is up 64% over the past year. The company is forecast to post earnings per share of CN¥1.06 for next year compared to CN¥0.45 last year. New Risk • Jul 04
New major risk - Revenue and earnings growth Earnings have declined by 5.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.1% per year over the past 5 years. Minor Risks High level of debt (81% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Annonce • Jun 30
SKSHU Paint Co.,Ltd. to Report First Half, 2025 Results on Aug 30, 2025 SKSHU Paint Co.,Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Buy Or Sell Opportunity • Jun 10
Now 21% undervalued Over the last 90 days, the stock has risen 3.3% to CN¥35.05. The fair value is estimated to be CN¥44.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.7% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 24% in 2 years. Earnings are forecast to grow by 146% in the next 2 years. New Risk • May 14
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks High level of debt (81% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Reported Earnings • Apr 27
First quarter 2025 earnings released: EPS: CN¥0.20 (vs CN¥0.09 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.20 (up from CN¥0.09 in 1Q 2024). Revenue: CN¥2.13b (up 3.1% from 1Q 2024). Net income: CN¥105.2m (up 123% from 1Q 2024). Profit margin: 4.9% (up from 2.3% in 1Q 2024). Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Annonce • Apr 26
SKSHU Paint Co.,Ltd., Annual General Meeting, May 16, 2025 SKSHU Paint Co.,Ltd., Annual General Meeting, May 16, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Putian, Fujian China Annonce • Mar 28
SKSHU Paint Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025 SKSHU Paint Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Major Estimate Revision • Feb 26
Consensus EPS estimates fall by 10% The consensus outlook for fiscal year 2024 has been updated. 2024 consensus EPS estimate fell from CN¥0.962 to CN¥0.863. Revenue forecast reaffirmed at CN¥12.9b. Net income forecast to grow 2,192% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥44.46. Share price rose 6.4% to CN¥46.95 over the past week. Annonce • Dec 27
SKSHU Paint Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 SKSHU Paint Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 Buy Or Sell Opportunity • Nov 22
Now 22% undervalued Over the last 90 days, the stock has risen 59% to CN¥43.51. The fair value is estimated to be CN¥55.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.1% over the last 3 years. Earnings per share has grown by 53%. Revenue is forecast to grow by 28% in 2 years. Earnings are forecast to grow by 2,896% in the next 2 years. Price Target Changed • Nov 13
Price target decreased by 9.2% to CN¥38.04 Down from CN¥41.92, the current price target is an average from 8 analysts. New target price is 21% below last closing price of CN¥47.99. Stock is down 18% over the past year. The company is forecast to post earnings per share of CN¥1.01 for next year compared to CN¥0.33 last year. Major Estimate Revision • Nov 06
Consensus EPS estimates fall by 15% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥13.4b to CN¥13.3b. EPS estimate also fell from CN¥0.98 per share to CN¥0.835 per share. Net income forecast to grow 2,164% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥40.67. Share price rose 22% to CN¥51.95 over the past week. New Risk • Nov 04
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 0.07x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.07x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Reported Earnings • Oct 31
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: CN¥0.38 (down from CN¥0.46 in 3Q 2023). Revenue: CN¥3.39b (down 7.9% from 3Q 2023). Net income: CN¥200.3m (down 18% from 3Q 2023). Profit margin: 5.9% (down from 6.6% in 3Q 2023). Revenue missed analyst estimates by 6.3%. Earnings per share (EPS) also missed analyst estimates by 54%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Oct 29
Now 23% undervalued Over the last 90 days, the stock has risen 30% to CN¥42.35. The fair value is estimated to be CN¥55.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.6% over the last 3 years. Earnings per share has grown by 34%. Revenue is forecast to grow by 28% in 2 years. Earnings are forecast to grow by 1,035% in the next 2 years. Annonce • Sep 30
SKSHU Paint Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024 SKSHU Paint Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Reported Earnings • Jul 27
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Second quarter 2024 results: EPS: CN¥0.31 (down from CN¥0.54 in 2Q 2023). Revenue: CN¥3.69b (flat on 2Q 2023). Net income: CN¥162.9m (down 43% from 2Q 2023). Profit margin: 4.4% (down from 7.7% in 2Q 2023). Revenue exceeded analyst estimates by 5.5%. Earnings per share (EPS) also surpassed analyst estimates by 90%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Jun 29
Now 21% undervalued Over the last 90 days, the stock has risen 13% to CN¥36.27. The fair value is estimated to be CN¥45.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 371% in the next 2 years. Annonce • Jun 28
SKSHU Paint Co.,Ltd. to Report First Half, 2024 Results on Jul 27, 2024 SKSHU Paint Co.,Ltd. announced that they will report first half, 2024 results on Jul 27, 2024 Price Target Changed • May 20
Price target decreased by 15% to CN¥38.76 Down from CN¥45.59, the current price target is an average from 8 analysts. New target price is 22% below last closing price of CN¥49.49. Stock is down 28% over the past year. The company is forecast to post earnings per share of CN¥1.12 for next year compared to CN¥0.33 last year. Major Estimate Revision • Apr 25
Consensus revenue estimates fall by 15% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥16.5b to CN¥14.0b. EPS estimate fell from CN¥2.06 to CN¥1.08 per share. Net income forecast to grow 260% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target down from CN¥59.38 to CN¥45.59. Share price was steady at CN¥31.06 over the past week. Reported Earnings • Apr 22
Third quarter 2023 earnings released: EPS: CN¥0.46 (vs CN¥0.40 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.46 (up from CN¥0.40 in 3Q 2022). Revenue: CN¥3.67b (up 13% from 3Q 2022). Net income: CN¥244.0m (up 19% from 3Q 2022). Profit margin: 6.6% (up from 6.3% in 3Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 4 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings. Annonce • Apr 21
SKSHU Paint Co.,Ltd., Annual General Meeting, May 10, 2024 SKSHU Paint Co.,Ltd., Annual General Meeting, May 10, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Putian, Fujian China Annonce • Mar 29
SKSHU Paint Co.,Ltd. to Report Q1, 2024 Results on Apr 20, 2024 SKSHU Paint Co.,Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024 Buy Or Sell Opportunity • Mar 20
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 20% to CN¥37.68. The fair value is estimated to be CN¥47.36, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 123% in the next 2 years. Price Target Changed • Mar 06
Price target decreased by 8.4% to CN¥62.85 Down from CN¥68.60, the current price target is an average from 8 analysts. New target price is 70% above last closing price of CN¥37.03. Stock is down 57% over the past year. The company is forecast to post earnings per share of CN¥1.57 for next year compared to CN¥0.63 last year. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥33.65, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 59% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥59.67 per share. Annonce • Dec 29
SKSHU Paint Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024 SKSHU Paint Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 20, 2024 Buying Opportunity • Dec 01
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 31%. The fair value is estimated to be CN¥67.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 50% in 2 years. Earnings is forecast to grow by 139% in the next 2 years. Major Estimate Revision • Oct 24
Consensus EPS estimates fall by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥14.1b to CN¥13.9b. EPS estimate also fell from CN¥1.77 per share to CN¥1.58 per share. Net income forecast to grow 86% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target of CN¥73.05 unchanged from last update. Share price fell 6.9% to CN¥56.00 over the past week. Price Target Changed • Oct 21
Price target decreased by 11% to CN¥73.05 Down from CN¥82.33, the current price target is an average from 9 analysts. New target price is 27% above last closing price of CN¥57.44. Stock is down 17% over the past year. The company is forecast to post earnings per share of CN¥1.65 for next year compared to CN¥0.63 last year. Major Estimate Revision • Oct 20
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from CN¥1.77 to CN¥1.58 per share. Revenue forecast steady at CN¥14.0b. Net income forecast to grow 87% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥82.33 to CN¥76.87. Share price fell 9.4% to CN¥57.44 over the past week. Buying Opportunity • Oct 19
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 19%. The fair value is estimated to be CN¥72.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 53% in 2 years. Earnings is forecast to grow by 147% in the next 2 years. Reported Earnings • Oct 14
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: EPS: CN¥0.46 (up from CN¥0.41 in 3Q 2022). Revenue: CN¥3.67b (up 13% from 3Q 2022). Net income: CN¥244.0m (up 19% from 3Q 2022). Profit margin: 6.6% (up from 6.3% in 3Q 2022). Revenue missed analyst estimates by 4.5%. Earnings per share (EPS) also missed analyst estimates by 15%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 7% per year. Reported Earnings • Jul 31
Second quarter 2023 earnings released: EPS: CN¥0.54 (vs CN¥0.25 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.54 (up from CN¥0.25 in 2Q 2022). Revenue: CN¥3.68b (up 22% from 2Q 2022). Net income: CN¥284.1m (up 111% from 2Q 2022). Profit margin: 7.7% (up from 4.5% in 2Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Major Estimate Revision • Jul 18
Consensus EPS estimates increase by 16% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate increased from CN¥1.70 to CN¥1.97. Revenue forecast steady at CN¥14.1b. Net income forecast to grow 159% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥79.67 to CN¥83.95. Share price was steady at CN¥67.25 over the past week. Annonce • Jun 27
SKSHU Paint Co.,Ltd. to Report First Half, 2023 Results on Jul 31, 2023 SKSHU Paint Co.,Ltd. announced that they will report first half, 2023 results on Jul 31, 2023 Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorates as stock falls 27% After last week's 27% share price decline to CN¥70.24, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥84.59 per share. Major Estimate Revision • May 11
Consensus EPS estimates increase by 16% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate increased from CN¥2.07 to CN¥2.40. Revenue forecast steady at CN¥14.0b. Net income forecast to grow 154% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥116 to CN¥114. Share price was steady at CN¥99.30 over the past week. Reported Earnings • May 04
Third quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.13 loss in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.13 loss in 3Q 2021). Revenue: CN¥3.24b (flat on 3Q 2021). Net income: CN¥204.8m (up CN¥253.8m from 3Q 2021). Profit margin: 6.3% (up from net loss in 3Q 2021). Revenue is forecast to grow 21% p.a. on average during the next 4 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance. Price Target Changed • Dec 12
Price target increased to CN¥115 Up from CN¥103, the current price target is an average from 9 analysts. New target price is approximately in line with last closing price of CN¥119. Stock is down 9.5% over the past year. The company is forecast to post earnings per share of CN¥1.52 next year compared to a net loss per share of CN¥1.11 last year. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Employee-Representative Chairman of Board of Supervisors Peng Yong Sen was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 30
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.13 loss in 3Q 2021). Revenue: CN¥3.24b (flat on 3Q 2021). Net income: CN¥204.8m (up CN¥253.8m from 3Q 2021). Profit margin: 6.3% (up from net loss in 3Q 2021). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 3.5%. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance. Reported Earnings • Sep 02
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Second quarter 2022 results: EPS: CN¥0.35 (up from CN¥0.28 in 2Q 2021). Revenue: CN¥3.01b (down 6.0% from 2Q 2021). Net income: CN¥134.6m (up 28% from 2Q 2021). Profit margin: 4.5% (up from 3.3% in 2Q 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 31%. Earnings per share (EPS) also missed analyst estimates by 19%. Over the next year, revenue is forecast to grow 40%, compared to a 33% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings. Price Target Changed • Jul 07
Price target increased to CN¥108 Up from CN¥98.26, the current price target is an average from 12 analysts. New target price is 15% below last closing price of CN¥127. Stock is down 27% over the past year. The company is forecast to post earnings per share of CN¥2.24 next year compared to a net loss per share of CN¥1.11 last year. Price Target Changed • May 07
Price target decreased to CN¥105 Down from CN¥118, the current price target is an average from 11 analysts. New target price is 27% above last closing price of CN¥83.00. Stock is down 52% over the past year. The company is forecast to post earnings per share of CN¥2.67 next year compared to a net loss per share of CN¥1.11 last year. Reported Earnings • May 02
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: CN¥0.10 loss per share (down from CN¥0.021 profit in 1Q 2021). Revenue: CN¥1.70b (up 14% from 1Q 2021). Net loss: CN¥38.7m (down CN¥46.8m from profit in 1Q 2021). Revenue missed analyst estimates by 14%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 45%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 48% per year, which means it is well ahead of earnings. Price Target Changed • Apr 27
Price target decreased to CN¥118 Down from CN¥140, the current price target is an average from 11 analysts. New target price is 70% above last closing price of CN¥69.12. Stock is down 54% over the past year. The company is forecast to post a net loss per share of CN¥1.08 compared to earnings per share of CN¥1.36 last year. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Buying Opportunity • Mar 03
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 29%. The fair value is estimated to be CN¥105, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 40% per annum over the last 3 years. Earnings per share has grown by 24% per annum over the last 3 years. Major Estimate Revision • Feb 02
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 EPS estimate fell from CN¥0.69 to CN¥0.42 per share. Revenue forecast steady at CN¥12.1b. Net income forecast to grow 227% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target of CN¥139 unchanged from last update. Share price fell 5.1% to CN¥106 over the past week. Price Target Changed • Nov 07
Price target decreased to CN¥143 Down from CN¥157, the current price target is an average from 12 analysts. New target price is 6.6% above last closing price of CN¥134. Stock is up 28% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥1.36 last year. Reported Earnings • Oct 31
Third quarter 2021 earnings released: CN¥0.13 loss per share (vs CN¥0.76 profit in 3Q 2020) The company reported a mediocre third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: CN¥3.22b (up 34% from 3Q 2020). Net loss: CN¥49.0m (down 123% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 101% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 17
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥106, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 577% over the past three years. Reported Earnings • Jul 31
Second quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.65 in 2Q 2020) The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥3.20b (up 48% from 2Q 2020). Net income: CN¥105.0m (down 55% from 2Q 2020). Profit margin: 3.3% (down from 11% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 116% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Jun 27
Price target decreased to CN¥162 Down from CN¥178, the current price target is an average from 8 analysts. New target price is 13% below last closing price of CN¥186. Stock is up 197% over the past year. Price Target Changed • Jun 10
Price target decreased to CN¥122 Down from CN¥162, the current price target is an average from 8 analysts. New target price is 26% below last closing price of CN¥164. Stock is up 156% over the past year. Major Estimate Revision • May 05
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast increased from CN¥11.2b to CN¥12.5b. EPS estimate unchanged from CN¥3.08 at last update. Chemicals industry in China expected to see average net income growth of 39% next year. Consensus price target up from CN¥154 to CN¥180. Share price rose 13% to CN¥237 over the past week. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.49 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.48b (up 241% from 1Q 2020). Net income: CN¥8.07m (up CN¥134.5m from 1Q 2020). Profit margin: 0.5% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has increased by 107% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Apr 29
Price target increased to CN¥167 Up from CN¥154, the current price target is an average from 10 analysts. New target price is 28% below last closing price of CN¥231. Stock is up 201% over the past year. Is New 90 Day High Low • Mar 01
New 90-day high: CN¥186 The company is up 35% from its price of CN¥138 on 01 December 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.08 per share. Is New 90 Day High Low • Feb 02
New 90-day high: CN¥167 The company is up 12% from its price of CN¥150 on 04 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.09 per share. Major Estimate Revision • Jan 23
Analysts update estimates The 2021 consensus revenue estimate increased from CN¥10.8b to CN¥11.0b. Earnings per share (EPS) estimate was lowered from CN¥3.23 to CN¥2.88 for the same period. Net income is expected to grow by 82% next year compared to 45% growth forecast for the Chemicals industry in China. The consensus price target was lowered from CN¥162 to CN¥160. Share price is up 1.7% to CN¥157 over the past week.